IPAB Back In The Spotlight As Repeal Bill Clears House Subcommittee
This article was originally published in The Pink Sheet Daily
House Energy and Commerce health panel votes to repeal IPAB; Ways and Means Committee plans a hearing in early March.
You may also be interested in...
CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old
CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.